BETHLEHEM, Pa.--(BUSINESS WIRE)--Saladax Biomedical, Inc (Saladax) is pleased to announce an exclusive distribution agreement with HLS Therapeutics Inc. (“HLS”) (TSX:HLS) to distribute five MyCare™ Psychiatry Laboratory Assays used to measure the six most commonly prescribed antipsychotic drugs in Canada.
DORVAL, QC, April 1, 2021 /CNW Telbec/ - HLS Therapeutics Inc. regrets the adoption of a new regulation, published yesterday in the Gazette officielle du Québec, which limits access to a support program for new patients suffering from refractory schizophrenia, and urgently requests a meeting with the Quebec Minister of Health and Social Services Christian Dubé.
HLS Therapeutics has announced that clinical results from the CardioLink-9 Trial showed Vascepa (icosapent ethyl) provided an anti-inflammatory effect in symptomatic Covid-19 infected outpatients.